Showing results (31-40 of 160) with videos related to
Sort By:
Pageof 16
Cardiovascular Diabetology|November 24, 2022
Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life dataHanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, et al.Kidney International|February 12, 2017
Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefitsJens Oellgaard, Peter Gæde, Peter Rossing, et al.Journal of Diabetes and Its Complications|May 4, 2015
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetesBernt Johan von Scholten, Tine Willum Hansen, Jens Peter Goetze, et al.Ugeskrift for Laeger|March 19, 2009
[Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication]Hans-Henrik Parving, Frederik Persson, Julia B Lewis, et al.The New England Journal of Medicine|June 6, 2008
Aliskiren combined with losartan in type 2 diabetes and nephropathyHans-Henrik Parving, Frederik Persson, Julia B Lewis, et al.Journal of Diabetes and Its Complications|September 9, 2015
The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medicationBernt Johan von Scholten, David Dynnes Ørsted, Anne Louise Svendsen, et al.Diabetes Care|June 22, 2019
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without AlbuminuriaDorte Vistisen, Gregers Stig Andersen, Adam Hulman, et al.Ugeskrift for Laeger|August 25, 2020
[SGLT 2 inhibitors in Type 1 diabetes]Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, et al.BMC Primary Care|June 21, 2023
Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and deathRikke Borg, Margit Kriegbaum, Mia Klinten Grand, et al.Diabetes Research and Clinical Practice|January 3, 2012
High YKL-40 levels predict mortality in patients with type 2 diabetesFrederik Persson, Camilla Noelle Rathcke, Mari-Anne Gall, et al.Pageof 16